Vistagen Therapeutics, Inc. (VTGN)
0.5632
+0.06
(+11.52%)
USD |
NASDAQ |
Feb 06, 16:00
0.5461
-0.02
(-3.04%)
After-Hours: 20:00
Vistagen Therapeutics SG&A Expense (TTM) : 17.01M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 32.68M |
| Omeros Corp. | 44.20M |
| GeoVax Labs, Inc. | 6.16M |
| Daré Bioscience, Inc. | 9.228M |
| Spero Therapeutics, Inc. | 23.93M |